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Abstract: Reelin depletion and stress seem to affect similar pathways including GABAergic and
glutamatergic signaling and both are implicated in psychiatric disorders in late adolescence/early
adulthood. The interaction between reelin depletion and stress, however, remains unclear.
To investigate this, male and female heterozygous reelin mice (HRM) and wildtype (WT) controls were
treated with the stress hormone, corticosterone (CORT), during late adolescence to simulate chronic
stress. Glucocorticoid receptors (GR), N-methyl-D-aspartate receptor (NMDAr) subunits, glutamic
acid decarboxylase (GAD67) and parvalbumin (PV) were measured in the hippocampus and the
prefrontal cortex (PFC) in adulthood. While no changes were seen in male mice, female HRM showed
a significant reduction in GR expression in the dorsal hippocampus. In addition, CORT reduced GR
levels as well as GluN2B and GluN2C subunits of NMDAr in the dorsal hippocampus in female
mice only. CORT furthermore reduced GluN1 levels in the PFC of female mice. The combined
effect of HRM and CORT treatment appeared to be additive in terms of GR expression in the
dorsal hippocampus. Female-specific CORT-induced changes were associated with overall higher
circulating CORT levels in female compared to male mice. This study shows differential effects of
reelin depletion and CORT treatment on GR and NMDAr protein expression in male and female mice,
suggesting that females are more susceptible to reelin haploinsufficiency as well as late-adolescent
stress. These findings shed more light on female-specific vulnerability to stress and have implications
for stress-associated mental illnesses with a female bias including anxiety and major depression.
Keywords: reelin; corticosterone; glucocorticoid receptors; NMDA receptors; parvalbumin; GAD67
1. Introduction
Reelin is an extracellular matrix protein that is secreted by Cajal-Retzius cells during embryonic
brain development and mainly by cortical and hippocampal GABAergic interneurons during
adulthood [1–3]. During brain development, reelin is predominantly involved in cortical layer
formation [1]. Mice with homozygous loss of reelin, called reeler mice, display inversion of cortex cell
layers and malposition of neurons throughout the hippocampus [4]. Heterozygous loss of reelin in mice
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induces a less severe phenotype showing dendritic abnormalities in the cortex and the hippocampus
and only subtle abnormalities in cognitive function [5–9]. These mice are used to investigate the role of
reelin in the development of psychiatric disorders as mutations in the reelin gene as well as decreased
levels of mRNA are associated with autism [10], schizophrenia and bipolar disorder [2,11].
Aside from its developmental role, reelin serves a crucial function in the mature brain acting
through its two major receptors, Apolipoprotein E receptor 2 (EpoER2) and very low-density lipoprotein
receptor (VLDLR) [12], activating numerous downstream cascades via Dab1 phosphorylation such
as Akt/mTOR or N-WASP leading to microtubule formation and actin stabilization, respectively [13].
In the mature brain, reelin signaling promotes dendritic spine maturation, synaptogenesis, synaptic
transmission and plasticity, and therefore plays a critical role in the modulation of synaptic
circuits [14–16]. In a comprehensive review of articles published from 1980 to 2014 on major depression
a main finding was the association between both chronic stress and major depression with dendritic
spine loss and aborization as well as reduced glial cells [17], thus disruption to reelin may be upstream
of this broad set of functional deficits associated with major depression.
Reelin signaling through ApoER2 was shown to activate NMDAR phosphorylation and calcium
influx through these receptors and subunit composition [18] thus mediating synaptic plasticity and
learning and memory [14,16].
NMDAr are tetramers consisting of two GluN1 subunits and two GluN2 subunits (GluN2A,
GluN2B, GluN2C and GluB2D). While NMDA receptors containing GluN2C and GluN2D are mainly
localized to the cerebellum and show slower kinetics compared to GluN2A and GluN2B in the adult
brain [19], GluN2A and GluN2B are highly expressed in the hippocampus and the cortex and are
critical mediators of synaptic function via regulating synaptic plasticity (reviewed in Sanz-Clemente,
Nicoll [20]). Reelin has also been closely linked to the markers of GABAergic interneurons: glutamic
acid decarboxylase (GAD67), the enzyme that converts glutamate to GABA, and parvalbumin (PV),
as these were simultaneously decreased with reelin mRNA and protein levels in the PFC and the
hippocampus in schizophrenia and bipolar post-mortem brains [21] as well as in mouse models of
these neuropsychiatric disorders [22,23]. Findings on the effect of reelin deficiency on the expression
of these GABAergic markers as well as NMDAr subunits remain inconsistent, possibly due to a lack
of stratification for sex. Nullmeier et al. [23] for example combined male and female data when
comparing GAD67 expression in reelin haploinsufficient and wild-type mice, and found a significant
decrease in GAD67 and PV in multiple hippocampal regions, but did not stratify for sex in the
analysis. Previously, we have shown sex differences in BDNF, TrkB and GluNR2C expression in
reelin haploinsufficient mice [24,25], while others have shown that male but not female Rln +/−
mice show alterations in steroid hormone levels in the cerebellum when compared to controls [26].
Due to the well-established sex differences within GABAergic development [27] as well as psychiatric
disorders [28,29], it is important to discern specific differences between males and females.
While several genetic variants have been associated with severe psychiatric disorders such
as major depression, no single gene is likely to be causative. Rather a gene × gene or gene ×
environment interaction is more probable. A well-accepted model to explain the complex and
heterogeneous aetiology of psychiatric disorders is the two-hit hypothesis, which suggests that early
genetic or environmental insults disrupt the developing brain causing it to be vulnerable to a second
environmental insult during adolescence, such as stress [30]. Reelin deficiency may constitute a risk
factor by making the brain more vulnerable to stress. In particular adolescent stress has been shown to
be a major environmental trigger for psychiatric illnesses as the brain still undergoes synaptic changes
and maturation, including of hypothalamic-pituitary-adrenal (HPA) axis activity [31], during this
vulnerable period of development. Chronic stress is well known for its detrimental effects on neuronal
morphology and function in brain regions such as the hippocampus and PFC [32,33] as these show the
highest density of the glucocorticoid receptors (GR), which bind the stress hormone cortisol (in humans)
and corticosterone (in rodents) [34]. In particular GABAergic interneurons as well as NMDA receptors
appear to be affected by stress [33,35,36], targets that are also vulnerable to reelin deficiency. While there
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is strong evidence that reelin deficiency and stress may affect common pathways, only a few studies
looked at the interaction underlying this genetic risk factor and the environmental insult mainly
focusing on the behavioral phenotype related to neuropsychiatric disorders [37,38]. We have previously
shown that heterozygous reelin mice (HRM) were more susceptible to CORT treatment with regards
to spatial memory [37], however, it remains unclear how reelin deficiency may increase susceptibility
to stress on the molecular level. This study sought to investigate a) how reelin deficiency or adolescent
stress impact the expression of NMDA receptor subunits, the GABAergic markers, GAD67 and PV,
as well as GR and b) whether reelin deficiency makes the brain more vulnerable to adolescent/early
adult stress which may explain the profound decrease in those markers in psychiatric disorders.
Given strong evidence for sex differences in HPA axis activity and responses to stress [39] as well as in
the incidence of psychiatric disorders such as major depression [28] and schizophrenia [29], we assessed
both male and female mice. We used HRM which show 50% reelin depletion [24]. Late-adolescent
stress was simulated by chronic corticosterone (CORT) administration [40]. We analyzed the PFC
and hippocampus, brain regions which are susceptible to stress and display high levels of reelin and
GR expression [34,41]. We hypothesized that the combined effect of reelin haploinsufficiency and
adolescent CORT treatment would cause alterations in GABAergic, glutamatergic and stress receptor
pathways but these may be differentially modulated according to sex.
2. Materials and Methods
2.1. Animals
Mice were derived from a breeding colony at the Florey Institute of Neuroscience and Mental
Health, Melbourne, Australia, and consisted of both male and female HRM and wild-type (WT) control
mice. The colony was originally established with Relnrl/+ (on a C57Bl/6J genetic background) and
crossed with C57Bl/6J breeders that were purchased from The Jackson Laboratory (Bar Harbor, ME,
USA). All mice were group-housed in individually-ventilated cages (IVC, Tecniplast, Buguggiate,
Italy) with ad libitum access to food and water, and kept on a 12/12 h light/dark cycle (lights on
7 a.m.). Cages were cleaned once a week. All procedures were conducted according to the guidelines
in the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (National
Health and Medical Research Council of Australia, 8th edition 2013) and approved by the Animal Ethics
Committee of the Florey Institute of Neuroscience and Mental Health.
2.2. Corticosterone Treatment
Mice received chronic CORT treatment in their drinking water [42,43] for 21 days starting from six
weeks of age until nine weeks. We based the treatment time window on our previous developmental
studies in C57Bl/6 mice, which showed a rapid rise in seminal vesicle weight, serum testosterone
and uterine weight around 6–9 weeks of age, which we accordingly describe as the late-adolescent
period [44]. CORT (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 100% ethanol and diluted
with tap water to a final concentration of 50 mg/L (0.5% ethanol). We used CORT treatment rather
than other stress paradigms in order to focus on glucocorticoid effects and its interaction with reelin
signaling. Stress paradigms (e.g., chronic restraint stress) elicit many physiological responses and many
broad molecular changes that differ compared to glucocorticoid-specific effects, making interpretation
of the data more complex. Control mice received a vehicle solution (0.5% ethanol in tap water).
After the three-week treatment period all mice received normal tap water and were left undisturbed
until 15 weeks of age, when the brains and adrenal glands were collected for molecular analyses to
detect long-term effects of CORT and/or reelin haploinsufficiency. Experimental groups consisted
of four male and four female groups: WT mice treated during adolescence with vehicle (WT Contr);
WT mice treated during adolescence with CORT (WT CORT); HRM treated during adolescence
with vehicle (HRM Contr) and HRM treated during adolescence with CORT (HRM CORT) (n = 7).
Body weight was recorded weekly from the beginning of the treatment.
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2.3. Detection of CORT
To detect CORT levels during treatment, without causing adverse stress from extracting blood,
we instead collected faecal boli. Samples were collected from their home cage at three time points:
week 6 (prior to the beginning of CORT treatment); week 9 (at the completion of the treatment period);
and week 11 (two weeks following cessation of treatment). The faecal boli were frozen in liquid
nitrogen and crushed using a pestle and mortar. One ml of methanol was added to 50 mg samples
and vortexed for 30 min, before collection of the supernatant. To detect CORT levels we used an
enzyme-immunoassay kit (Cayman Chemical Company, Ann Arbor, MI, USA). With samples used
at a 1:50 dilution. Touma, Palme [45], have previously detected CORT levels in the faeces of male
and female rodents and report this technique as a robust measure of pharmacological stimulation and
suppression of adrenocortical activity. Accurate representation of CORT by means of faecal CORT
measurements was also supported by other studies [46,47].
2.4. Western Blot Analysis
Mice were killed by cervical dislocation at 15 weeks of age and their adrenal glands and
brains were collected and stored at −80 ◦C. The prefrontal cortex and hippocampus were dissected
and the hippocampus was separated into ventral and dorsal hippocampus (approximately 50/50).
All dissections were performed by the same researcher to ensure consistent dissection ratios.
Protein extraction and Western blot analysis were performed as previously described by Klug, Hill [40]
and Buret and van den Buuse [24]. The primary antibodies were anti-glucocorticoid receptor (GR)
(97 kDa, 1:500, ab2768, Abcam), anti-NMDAr2C (1:500, ab110, Abcam) which recognizes 180 kDa
GluN2B, 140 kDa GluN2C and 120 kDa GluN1 subunits, anti-NMDAr2A (170 kDa, 1:1000, ab14596,
Abcam), anti-parvalbumin (12 kDa, 1:2000, MAB1572, Millipore), and anti-GAD67 (67 kDa, 1:1000,
Sigma-Aldrich).
2.5. Statistical Analysis
Data are expressed as mean ± standard error of the mean (SEM). Group differences were assessed
with SYSTAT 13 (Systat Software Inc., San Jose, CA, USA). Five to six mice per group were used to
analyze CORT levels as well as all presented protein levels. Relative adrenal weights as well as all
Western blot results were analysed using three-way analysis of variance (ANOVA) with sex, genotype
and (CORT) treatment as between-group factors. Faecal CORT levels were analyzed by means of
repeated measures ANOVA with the same between-factors and time as a within-group factor. In all
cases, the significance level was set to p ≤ 0.05.
3. Results
3.1. Adrenal Weight
Statistical analysis of relative adrenal weight at 15 weeks of age revealed a main treatment effect
(F(1,82) = 9.5, p = 0.003) and a sex effect (F(1,82) = 271.0, p < 0.001). This reflected that the adrenal glands
were considerably larger in females than males and that CORT-treated mice had smaller adrenals
compared to their non-treated controls, irrespective of sex or genotype (Table 1). Body weight was
smaller in females compared to males as expected and no differences were detected between the CORT
and HRM groups at week 15 (data not shown).
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Table 1. Relative adrenal weight.
Male Female
WT Contr 1.13 ± 0.05 2.10 ± 0.11 #
HRM Contr 1.13 ± 0.09 1.97 ± 0.09 #
WT CORT 0.92 ± 0.02 * 1.85 ± 0.09 *,#
HRM CORT 0.96 ± 0.08 * 1.82 ± 0.08 *,#
Data are represented as mean ± SEM of n = 8–16; Relative adrenal weight was calculated as adrenal weight/body
weight × 10,000; * p < 0.05 for difference between CORT groups and controls as shown by ANOVA main
effect; # p < 0.05 for significant sex difference as shown by ANOVA main effect; heterozygous reelin mice (HRM);
wildtype (WT).
3.2. CORT Levels
Repeated measures ANOVA of faecal CORT revealed a main effect of sex (F(1,26) = 19.3,
p < 0.001), reflecting three-fold higher CORT levels in female compared to male mice, as well as
a day × CORT interaction (F(2,52) = 6.7, p = 0.003) (Figure 1). Further analysis separated by time
points of measurement (days: day 0—before CORT treatment, day 21—last day of CORT treatment,
day 35—2 weeks after cessation of CORT treatment) showed a main sex effect for all three days (day 0:
F(1,31) = 27.4, p < 0.001; day 21: F(1,33) = 5.7, p = 0.022; day 35: F(1,30) = 34.2, p < 0.001). No treatment
or genotype differences were observed on days 0 and 35, while a main treatment effect (F(1,33) = 6.3,
p = 0.018) was detected on day 21 reflected higher CORT levels in CORT-treated male and female
groups versus vehicle-treated controls (Figure 1).
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Figure 1. CORT levels in faecal boli at day 0 (before start of CORT treatment), day 21 (last day of
CORT treatment) and day 35 (2 weeks after cessation of CORT treatment) in WT vehicle-treated mice
(white bars), HRM vehicle-treated mice (lined bars), WT CORT-treated mice (black bars) and HRM
CORT-treated mice (c ecked bars) Data are expressed as mean ± SEM (n = 4–6). A main treatment
effect was observed on day 21 with higher CORT levels in CORT-treated groups (black a d checked
bars) compared to c trols (* p < 0.05). Female mice showed significantly higher CORT levels than
male mice at all three time points of measurement. No treatment or genotype differences were detected
on days 0 or day 35. Heterozyg us reelin mice (HRM); wild ype (WT).
3.3. GR Expression
Statistical analysis of GR protein expression in the dorsal hippocampus (Figure 2A) revealed a
significant sex × CORT interaction (F(1,39) = 3.05; p = 0.01). Further separate analyses of males and
females showed a main CORT effect (F(1,19) = 7.37; p < 0.05) and a main genotype effect (F(1,19) = 7.02;
p < 0.05) in females only, reflecting reduced levels of GR in the CORT-treated females as well as in
HRM as compared to their respective control groups (Figure 2A). While no significant genotype ×
CORT interaction was found in females, the HRM + CORT group showed the lowest expression levels
of GR. No significant differences in GR expression were detected in the dorsal hippocampus of males.
No effects of genotype or CORT on GR expression were detected in the ventral hippocampus or PFC
of either male or female mice.
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Heterozygous reelin mice (HRM); wildtype (WT).
3.4. NMDAr Protein Expression
3.4.1. NMDAr Subunit Protein Expression in the Dorsal Hippocampus (Figure 3A–D)
While CORT had no effect on NMDAr expression in the dorsal hippocampus of male mice,
it significantly reduced GluN2B and GluN2C subunit levels in female mice (Figure 3C,D). This was
supported by an overall sex× CORT interaction (GluN2B: F(1,39) = 4.62; p < 0.05) GluN2C: F(1,39) = 9.1;
p = 0.004) and further main CORT effects when data from female mice were analyzed separately
(GluN2B: F(1,20) = 4.81; p = 0.04, GluN2C: F(1,20) = 11.15; p = 0.003). For GluN2C expression, a main
sex effect was seen in vehicle-treated mice (F(1,20 = 12.47; p = 0.002) reflecting higher levels of GluN2C
in females compared to male mice (Figure 3D). No differences were detected for GluN1 and GluN2A
between the groups (Figure 3A,B).
3.4.2. NMDAr Protein Expression in Ventral Hippocampus (Figure 3E–H)
Protein expression of GluN2C was lower in females as compared to male mice in the ventral
hippocampus as shown by the main sex effect (F(1,34) = 9.20; p = 0.005) (Figure 3H). No significant
effects of CORT, genotype or genotype× CORT interactions were observed in the ventral hippocampus
for any of the subunits (Figure 3E–H).
3.4.3. NMDAr Protein Expression in PFC (Figure 3I–L)
With regards to GluN1 expression in the PFC (Figure 3I), statistical analysis revealed a significant
sex × CORT interaction (F(1,40 = 7.01; p < 0.05). Further analysis showed that CORT significantly
reduced GluN1 protein expression in female mice (F(1,20) = 6.11; p < 0.05), while no significant
differences were observed in males. Within the vehicle-treated groups a significant main sex effect
was observed (F(1,20) = 5.53; p = 0.029) reflecting lower GluN1 levels in males compared to females
(Figure 3I). No significant statistical differences were seen for the subunits GluN2A, GluN2B or GluN2C
in the PFC (Figure 3J–L).
No significant effect of genotype and no genotype× CORT interaction was found for any NMDAr
subtypes in any of the 3 brain regions.
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and GluN2C (D,H,L) in the dorsal hippocampus (dHip) (A–D), ventral hippocampus (vHip) (E–H)
and prefrontal cortex (PFC) (I–L). Data are represented as mean ± SEM (n = 4–6). Analysis revealed
no differences in GluN1 (A) or GluNRA (B) in the dHip. However, a female-specific reduction
in GluN2B (C) and GluN2C (D) was found in response to CORT in the dHip (* p < 0.05), and in
vehicle-treated animals GluN2C levels (D) were higher in female mice compared to male mice
(# p < 0.05). No differences were detected between the experimental groups in the vHip (E–H), although
female mice had lower levels of GluN2C (H) compared to males (** p < 0.01). In the PFC CORT reduced
GluN1 (I) in female mice irrespective of the genotype (* p < 0.05), while in vehicle-treated animals
GluN1 was higher in female mice compared to male mice (# p < 0.05). No significant differences were
seen in GluN2A (J), GluN2B (K) or GluN2C (L) levels in PFC between the groups. Heterozygous reelin
mice (HRM); wildtype (WT).
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3.5. PV and GAD67 Protein Expression
No significant effects of CORT or genotype and no genotype × CORT interactions were detected
on PV or GAD67 protein expression in the dorsal hippocampus, ventral hippocampus or the PFC
(Figure 4).
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of corticosteroid-binding globulin (CBG) [49], a large number of studies demonstrate higher plasma
CORT levels in females as compared to males [50–53]. An explanation for lower CORT metabolite
expression in males might be the protective role of testosterone. A large number of studies have shown
that androgens inhibit the HPA axis. Basal CORT levels are increased in male rats after gonadectomy
(GDX) [51,54,55]. Blockade of the androgen receptor in adult male rats prior to restraint stress resulted
in elevated CORT and ACTH responses [56,57]. Concomitantly, the female hormone, 17β-estradiol
(E2), seems to maintain CORT at higher levels. Several studies reported decreased CORT levels as well
adrenal weight after ovariectomy, which were reversed by E2 treatment [58,59]. In agreement with this
observation and our results, Weathington, Arnold [60] showed that female rats were more severely
affected by juvenile stress compared to males and showed higher circulating CORT levels.
The 3-fold higher level of CORT in the females compared to males in our study may explain
the female-specific reduction in NMDAr subunits as well as GR expression. CORT reduced GR
protein levels in the dorsal hippocampus of female mice, an area with the highest GR expression [34],
which plays a crucial role in the feedback regulation of the HPA axis [61]. The majority of GRs are
nuclear receptors that directly bind CORT and elicit either gene transcription or gene repression via
binding to glucocorticoid receptor elements (GRE) on DNA [62]. Overstimulation of this receptor
by extremely high CORT levels may have induced downregulation of GR, most likely through the
ubiquitin proteasome pathway [63] to regulate transcription levels.
Interestingly, we also observed a female-specific reduction of GR in HRM versus WT controls,
reflecting that reelin deficiency leads to reduced GR expression in the dorsal hippocampus in females
only. GR is expressed in almost every cell type throughout the body and brain [64,65] with high
abundancy in the hippocampus and PFC [34,66]. Extensive evidence shows that reelin promotes
dendrite and spine formation during early development, particularly in the hippocampus and the
cortex [9,15]. Korn et al. [67] recently showed that abnormal reelin signaling decreased neurogenesis
and increased the number of hilar ectopic dentate granule cells in adult mice. According to the
GeneMANIA prediction server [68] as well as the literature there is no evidence for a direct physical
interaction between reelin and GR receptors, hence the GR reduction found here is most likely the result
of an indirect or compensatory response to reelin deficiency. Lower GR levels in female reelin-deficient
mice may also be due to lower numbers of neurons and dendrites in these animals. Further studies are
needed to investigate whether there are sex differences in neuronal expression, dendrite formation
and what type of cells are affected specifically in reelin haploinsufficient models. However, prenatal
treatment with the corticosteroid dexamethasone was previously shown to reduce hippocampal
calretinin expression in female but not male rats [69], suggesting a female-specific vulnerability of
these cells that are known to co-express reelin [70]. Our finding of female-specific susceptibility
to reelin deficiency is supported by studies showing that a single nucleotide polymorphism (SNP)
with the RELN gene sequence increases the risk of schizophrenia in women, but not in men [71,72].
In this study we show an additive effect of reelin deficiency and CORT treatment on GR expression in
female mice.
We further showed that late-adolescent CORT treatment reduced GluN2B and GluN2C subunits
of the NMDA receptor in the dorsal hippocampus and GluN1 in the PFC of female but not male
mice. We [24] previously reported that CORT reduced GluN2C protein levels in male mice in the
PFC and dorsal hippocampus independent of the genotype. We did not detect this change in this
study, which may be explained by the different CORT dose used (25 mg/L vs. 50 mg/L in the
present study). The direct effect of CORT on NMDA receptors is supported by an in vitro study
showing that CORT application reduces calcium influx through NMDA receptors in hippocampal
slices [73]. Reelin also modulates calcium influx through the NMDA receptors, however our study
shows that while CORT also modifies GluN1 receptor expression, reelin haploinsufficiency does not.
Zhang et al. [74] further demonstrated that glucocorticoids suppress NMDAr activity by acting on
putative non-genomic G-protein-coupled receptors activating the phospholipase C (PLC) pathway.
Hence, GluN2B downregulation may result from a direct interaction with the receptor through the PLC
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pathway or may be subsequent to changes in other molecules. Once again, the female-specific CORT
effect on NMDAr subunits may be due to the 3-fold higher CORT levels as compared to males. Van den
Buuse et al. [75] previously reported significant up-regulation of NR1 subunits, but down-regulation
of NR2C subunits in PFC of male and female HRM, while we could not detect these differences in
the current study. This may be due to the fact that van den Buuse et al. [75] collected the brains
starting at 12 weeks of age, while we looked at the brains from 15 week old mice. Furthermore,
while we separated male and female groups, van den Buuse et al. [75] combined the two sexes for
statistical analysis.
Reelin has been implicated in the regulation of PV and GAD67 expression [23,76–78], however we
did not find any differences in PV or GAD67 levels in any of the three brain areas. Supporting
our results, Lussier at al. [79] did not detect changes in hippocampal GAD67 expression in HRM.
By contrast, as opposed to our findings, Costa et al. [78] showed depletion of GAD67 in the frontal
cortex of HRM and Nullmeier et al. [23] demonstrated reduced GAD67 and PV in the hippocampus
of HRM. The contradicting results may be due to different techniques and brain regions used for
analysis. While Nullmeier et al. [23] compared sub-regions of the hippocampus such as CA1, CA2 or
dentate gyrus by means of immunohistochemistry, we performed Western blots on ventral and dorsal
hippocampi. Nullmeier et al. [23] analyzed male and female groups together, while other studies that
are mentioned used only males for detection of PV and GAD67, which may explain contradicting
results. Differences in age of the analyzed brain as well as housing conditions may also contribute to
inconsistent results in the literature. While early-life stress and chronic isolation stress were shown to
reduce PV in the hippocampus [80], pharmacological stress during late-adolescence in our study did
not affect PV or GAD67. The former study, however, did not look at the long-term effects of chronic
stress, but obtained tissue samples immediately at the end of the stress paradigm, whereas our study
included 6 weeks of washout period after treatment cessation. It is possible that in our animals, some
early CORT-induced changes in molecular markers could have been restored by this time. Therefore,
different types of stress and different periods of stress application may have differential effects on
these proteins. Furthermore, cellular distribution of these proteins may have been overlooked and
immunohistochemical analysis would be of relevance to confirm these results. Indeed, a limitation of
this study is the lack of cellular specificity afforded by the use of tissue homogenates for Western blot
analysis. Future studies using immunohistochemistry techniques to identify cell-specific alterations
in GR expression, as well as GABAergic markers in this two-hit model would be advantageous.
In addition, an important caveat to this study is that the brain tissue was removed 6 weeks following
the chronic corticosterone treatment, with the intention to assess the long term effects of adolescent
exposure to corticosterone. Here a parallel group, whereby tissue was collected immediately following
or during corticosterone treatment would be a good comparison to compare immediate and long term
effects of corticosterone on these protein targets.
In conclusion, CORT reduced NMDAr subunit expression in the dorsal hippocampus and PFC in
female, but not male mice. A female specific reduction of GR in response to CORT was also observed
in the dorsal hippocampus, which may be explained by the 3-fold higher CORT levels in females
compared to male mice during the treatment period. In addition, GR expression was decreased in
female HRM. Albeit reelin depletion did not enhance the effects of CORT on protein expression of
NMDAr subunits, GR, GAD67 or PV as measured by Western blot analysis, an additive effect of reelin
depletion and CORT on GR expression was observed in female but not male dorsal hippocampus.
This is an important direction for future studies as reelin deficiency as well as stress and related
HPA–axis dysregulation play a major role in the pathophysiology of numerous mental disorders,
such as MDD or schizophrenia. In addition, a major advantage of this study was the incorporation
of sex as a biological variate. Here we found distinct changes in female mice that may not have
been uncovered if both sexes were combined, and that provide important direction for future studies
investigating the potential role of sex steroid hormones in modulating reelin and stress-induced
molecular changes.
Brain Sci. 2018, 8, 118 11 of 15
Author Contributions: Conceptualization, A.S., M.v.d.B. and R.A.H.; Data curation, A.S.; Formal analysis, A.S.
and R.A.H.; Funding acquisition, A.S., M.v.d.B. and R.A.H.; Investigation, A.S.; Methodology, A.S., M.v.d.B. and
R.A.H.; Project administration, M.v.d.B. and R.A.H.; Resources, M.v.d.B. and R.A.H.; Supervision, M.v.d.B. and
R.A.H.; Writing—original draft, A.S.; Writing—review & editing, M.v.d.B. and R.A.H.
Acknowledgments: This research was undertaken at The Florey Institute of Neuroscience and Mental Health,
Melbourne, Australia, supported by project grant funding from the National Health and Medical Research
Council of Australia (NHMRC). A.S. was in receipt of a Melbourne International Research Scholarship as well
as a Melbourne International Fee Remission Scholarship. M.v.d.B. was supported by a NHMRC senior research
fellowship. R.A.H. was supported by a NHMRC Career Development Fellowship. This funding body had no
involvement in the study design, the collection, analysis and interpretation of data, or the writing of the paper
and the decision to submit it for publication.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Darcangelo, G.; Miao, G.G.; Chen, S.C.; Soares, H.D.; Morgan, J.I.; Curran, T. A protein related to extracellular
matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374, 719–723. [CrossRef] [PubMed]
2. Pesold, C.; Impagnatiello, F.; Pisu, M.G.; Uzunov, D.P.; Costa, E.; Guidotti, A.; Caruncho, H.J. Reelin is
preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of
adult rats. Proc. Natl. Acad. Sci. USA 1998, 95, 3221–3226. [CrossRef] [PubMed]
3. DelRio, J.A.; Heimrich, B.; Borrell, V.; Forster, E.; Drakew, A.; Alcantara, S.; Nakajima, K.; Miyata, T.;
Ogawa, M.; Mikoshiba, K.; et al. A role for Cajal-Retzius cells and reelin in the development of hippocampal
connections. Nature 1997, 385, 70–74. [CrossRef] [PubMed]
4. Goldowitz, D.; Cushing, R.C.; Laywell, E.; Darcangelo, G.; Sheldon, M.; Sweet, H.O.; Davisson, M.;
Steindler, D.; Curran, T. Cerebellar disorganization characteristic of reeler in scrambler mutant mice despite
presence of reelin. J. Neurosci. 1997, 17, 8767–8777. [CrossRef] [PubMed]
5. Brigman, J.L.; Padukiewicz, K.E.; Sutherland, M.L.; Rothblat, L.A. Executive functions in the heterozygous
reeler mouse model of schizophrenia. Behav. Neurosci. 2006, 120, 984–988. [CrossRef] [PubMed]
6. Podhorna, J.; Didriksen, M. The heterozygous reeler mouse: Behavioural phenotype. Behav. Brain Res. 2004,
153, 43–54. [CrossRef] [PubMed]
7. Tueting, P.; Doueiri, M.S.; Guidotti, A.; Davis, J.M.; Costa, E. Reelin down-regulation in mice and psychosis
endo-phenotypes. Neurosci. Biobehav. Rev. 2006, 30, 1065–1077. [CrossRef] [PubMed]
8. Larson, J.; Hoffman, J.S.; Guidotti, A.; Costa, E. Olfactory discrimination learning deficit in heterozygous
reeler mice. Brain Res. 2003, 971, 40–46. [CrossRef]
9. Lee, G.H.; D’Arcangelo, G. New Insights into Reelin-Mediated Signaling Pathways. Front. Cell. Neurosci.
2016, 10, 8. [CrossRef] [PubMed]
10. Skaar, D.A.; Shao, Y.; Haines, J.L.; Stenger, J.E.; Jaworski, J.; Martin, E.R.; DeLong, G.R.; Moore, J.H.;
McCauley, J.L.; Sutcliffe, J.S.; et al. Analysis of the RELN gene as a genetic risk factor for autism.
Mol. Psychiatry 2005, 10, 563–571. [CrossRef] [PubMed]
11. Guidotti, A.; Auta, J.; Davis, J.M.; Gerevini, V.D.; Dwivedi, Y.; Grayson, D.R.; Impagnatiello, F.; Pandey, G.;
Pesold, C.; Sharma, R.; et al. Decrease in reelin and glutamic acid decarboxylase(67) (GAD(67)) expression in
schizophrenia and bipolar disorder—A postmortem brain study. Arch. Gen. Psychiatry 2000, 57, 1061–1069.
[CrossRef] [PubMed]
12. Trommsdorff, M.; Gotthardt, M.; Hiesberger, T.; Shelton, J.; Stockinger, W.; Nimpf, J.; Hammer, R.E.;
Richardson, J.A.; Herz, J. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking
the VLDL receptor and ApoE receptor 2. Cell 1999, 97, 689–701. [CrossRef]
13. Beffert, U.; Morfini, G.; Bock, H.H.; Reyna, H.; Brady, S.T.; Herz, J. Reelin-mediated signaling locally regulates
protein kinase B/Akt and glycogen synthase kinase 3 beta. J. Biol. Chem. 2002, 277, 49958–49964. [CrossRef]
[PubMed]
14. Campo, C.; Sinagra, M.; Verrier, D.; Manzoni, O.J.; Chavis, P. Reelin Secreted by GABAergic Neurons
Regulates Glutamate Receptor Homeostasis. PLoS ONE 2009, 4. [CrossRef] [PubMed]
15. Iafrati, J.; Orejarena, M.J.; Lassalle, O.; Bouamrane, L.; Gonzalez-Campo, C.; Chavis, P. Reelin, an extracellular
matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex
via GluN2B-NMDARs and the mTOR pathway. Mol. Psychiatry 2014, 19, 417–426. [CrossRef] [PubMed]
Brain Sci. 2018, 8, 118 12 of 15
16. Ventruti, A.; Kazdoba, T.M.; Niu, S.; D’Arcangelo, G. Reelin deficiency causes specific defects in the molecular
composition of the synapses in the adult brain. Neuroscience 2011, 189, 32–42. [CrossRef] [PubMed]
17. Serafini, G.; Hayley, S.; Pompili, M.; Dwivedi, Y.; Brahmachari, G.; Girardi, P.; Amore, M. Hippocampal
neurogenesis, neurotrophic factors and depression: Possible therapeutic targets? CNS Neurol. Disord.
Drug Targets 2014, 13, 1708–1721. [CrossRef] [PubMed]
18. Sinagra, M.; Verrier, D.; Frankova, D.; Korwek, K.M.; Blahos, J.; Weeber, E.J.; Manzoni, O.J.; Chavis, P. Reelin,
very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor
composition during hippocampal maturation in vitro. J. Neurosci. 2005, 25, 6127–6136. [CrossRef] [PubMed]
19. Farrant, M.; Feldmeyer, D.; Takahashi, T.; Cullcandy, S.G. NMDA-receptor channel diversity in the
developing cerebellum. Nature 1994, 368, 335–339. [CrossRef] [PubMed]
20. Sanz-Clemente, A.; Nicoll, R.A.; Roche, K.W. Diversity in NMDA Receptor Composition: Many Regulators,
Many Consequences. Neuroscientist 2013, 19, 62–75. [CrossRef] [PubMed]
21. Costa, E.; Pesold, C.; Auta, J.; Caruncho, H.; Davis, J.M.; Davidkova, G.; Dwivedi, Y.; Grayson, D.R.;
Rodriguez, M.; Uzunov, D.; et al. Reelin and GAD67 downregulation and psychosis vulnerability.
Biol. Psychiatry 2000, 47, 68S. [CrossRef]
22. Giovanoli, S.; Weber, L.; Meyer, U. Single and combined effects of prenatal immune activation and
peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav. Immun.
2014, 40, 48–54. [CrossRef] [PubMed]
23. Nullmeier, S.; Panther, P.; Dobrowolny, H.; Frotscher, M.; Zhao, S.; Schwegler, H.; Wolf, R. Region-specific
alteration of GABAergic markers in the brain of heterozygous reeler mice. Eur. J. Neurosci. 2011, 33, 689–698.
[CrossRef] [PubMed]
24. Buret, L.; van den Buuse, M. Corticosterone treatment during adolescence induces down-regulation of
reelin and NMDA receptor subunit GLUN2C expression only in male mice: Implications for schizophrenia.
Int. J. Neuropsychopharmacol. 2014, 17, 1221–1232. [CrossRef] [PubMed]
25. Hill, R.A.; Wu, Y.W.; Gogos, A.; van den Buuse, M. Sex-dependent alterations in BDNF-TrkB signaling in the
hippocampus of reelin heterozygous mice: A role for sex steroid hormones. J. Neurochem. 2013, 126, 389–399.
[CrossRef] [PubMed]
26. Biamonte, F.; Assenza, G.; Marino, R.; D’Amelio, M.; Panteri, R.; Caruso, D.; Scurati, S.; Yague, J.G.;
Garcia-Segura, L.M.; Cesa, R.; et al. Interactions between neuroactive steroids and reelin haploinsufficiency
in Purkinje cell survival. Neurobiol. Dis. 2009, 36, 103–115. [CrossRef] [PubMed]
27. McCarthy, M.M.; Auger, A.P.; Perrot-Sinal, T.S. Getting excited about GABA and sex differences in the brain.
Trends Neurosci. 2002, 25, 307–312. [CrossRef]
28. Bekker, M.H.J.; van Mens-Verhulst, J. Anxiety disorders: Sex differences in prevalence, degree,
and background, but gender-neutral treatment. Gend. Med. 2007, 4, S178–S193. [CrossRef]
29. Falkenburg, J.; Tracy, D.K. Sex and schizophrenia: A review of gender differences. Psychosis 2014, 6, 61–69.
[CrossRef]
30. Maynard, T.M.; Sikich, L.; Lieberman, J.A.; LaMantia, A.S. Neural development, cell-cell signaling, and the
“two-hit” hypothesis of schizophrenia. Schizophr. Bull. 2001, 27, 457–476. [CrossRef] [PubMed]
31. Klein, Z.A.; Romeo, R.D. Changes in hypothalamic-pituitary-adrenal stress responsiveness before and after
puberty in rats. Horm. Behav. 2013, 64, 357–363. [CrossRef] [PubMed]
32. Gilabert-Juan, J.; Bueno-Fernandez, C.; Castillo-Gomez, E.; Nacher, J. Reduced interneuronal dendritic
arborization in CA1 but not in CA3 region of mice subjected to chronic mild stress. Brain Behav. 2017, 7.
[CrossRef] [PubMed]
33. Ghosal, S.; Hare, B.D.; Duman, R.S. Prefrontal cortex GABAergic deficits and circuit dysfunction in the
pathophysiology and treatment of chronic stress and depression. Curr. Opin. Behav. Sci. 2017, 14, 1–8.
[CrossRef] [PubMed]
34. Oitzl, M.S.; Champagne, D.L.; van der Veen, R.; de Kloet, E.R. Brain development under stress: Hypotheses
of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 2010, 34, 853–866. [CrossRef] [PubMed]
35. Zhu, Z.M.; Wang, G.Y.; Ma, K.; Cui, S.; Wang, J.H. GABAergic neurons in nucleus accumbens are correlated
to resilience and vulnerability to chronic stress for major depression. Oncotarget 2017, 8, 35933–35945.
[CrossRef] [PubMed]
Brain Sci. 2018, 8, 118 13 of 15
36. Pillai, A.G.; Arp, M.; Velzing, E.; Lesuis, S.L.; Schmidt, M.V.; Holsboer, F.; Joels, M.; Krugers, H.J. Early life
stress determines the effects of glucocorticoids and stress on hippocampal function: Electrophysiological
and behavioral evidence respectively. Neuropharmacology 2018, 133, 307–318. [CrossRef] [PubMed]
37. Schroeder, A.; Buret, L.; Hill, R.; van den Buuse, M. Gene-environment interaction of reelin and stress in
cognitive behaviours in mice: Implications for schizophrenia. Behav. Brain Res. 2015, 287, 304–314. [CrossRef]
[PubMed]
38. Lussier, A.L.; Romay-Tallon, R.; Kalynchuk, L.E.; Caruncho, H.J. Reelin as a putative vulnerability factor
for depression: Examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice.
Neuropharmacology 2011, 60, 1064–1074. [CrossRef] [PubMed]
39. Goel, N.; Workman, J.L.; Lee, T.T.; Innala, L.; Viau, V. Sex differences in the HPA axis. Compr. Physiol. 2014, 4,
1121–1155. [PubMed]
40. Klug, M.; Hill, R.A.; Choy, K.H.C.; Kyrios, M.; Hannan, A.J.; van den Buuse, M. Long-term behavioral and
NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice. Neurobiol. Dis.
2012, 46, 722–731. [CrossRef] [PubMed]
41. Herz, J.; Chen, Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 2006, 7, 850–859.
[CrossRef] [PubMed]
42. Karatsoreos, I.N.; Bhagat, S.M.; Bowles, N.P.; Weil, Z.M.; Pfaff, D.W.; McEwen, B.S. Endocrine and
Physiological Changes in Response to Chronic Corticosterone: A Potential Model of the Metabolic Syndrome
in Mouse. Endocrinology 2010, 151, 2117–2127. [CrossRef] [PubMed]
43. Notaras, M.J.; Vivian, B.; Wilson, C.; van den Buuse, M. Interaction of reelin and stress on immobility in the
forced swim test but not dopamine-mediated locomotor hyperactivity or prepulse inhibition disruption:
Relevance to psychotic and mood disorders. Schizophr. Res. 2017. [CrossRef] [PubMed]
44. Hill, R.A.; Wu, Y.W.C.; Kwek, P.; van den Buuse, M. Modulatory Effects of Sex Steroid Hormones on
Brain-Derived Neurotrophic Factor-Tyrosine Kinase B Expression during Adolescent Development in
C57Bl/6 Mice. J. Neuroendocrinol. 2012, 24, 774–788. [CrossRef] [PubMed]
45. Touma, C.; Palme, R.; Sachser, N. Analyzing corticosterone metabolites in fecal samples of mice:
A noninvasive technique to monitor stress hormones. Horm. Behav. 2004, 45, 10–22. [CrossRef] [PubMed]
46. Thanos, P.K.; Cavigelli, S.A.; Michaelides, M.; Olvet, D.M.; Patel, U.; Diep, M.N.; Volkow, N.D.
A Non-Invasive Method for Detecting the Metabolic Stress Response in Rodents: Characterization and
Disruption of the Circadian Corticosterone Rhythm. Physiol. Res. 2009, 58, 219–228. [PubMed]
47. Ninnes, C.E.; Waas, J.R.; Ling, N.; Nakagawa, S.; Banks, J.C.; Bell, D.G.; Bright, A.; Carey, P.W.; Chandler, J.;
Hudson, Q.J.; et al. Comparing plasma and faecal measures of steroid hormones in Adelie penguins
Pygoscelis adeliae. J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 2010, 180, 83–94. [CrossRef] [PubMed]
48. Raps, D.; Barthe, P.L.; Desaulle, P. Plasma and adrenal corticosterone levels during the different phases of
the sexual cycle in normal female rats. Experientia 1971, 27, 339–340. [CrossRef] [PubMed]
49. Gala, R.R.; Westphal, U. Corticosteroid-Binding Globulin in the Rat: Studies on the Sex Difference.
Endocrinology 1965, 77, 841–851. [CrossRef] [PubMed]
50. Atkinson, H.C.; Waddell, B.J. Circadian variation in basal plasma corticosterone and adrenocorticotropin
in the rat: Sexual dimorphism and changes across the estrous cycle. Endocrinology 1997, 138, 3842–3848.
[CrossRef] [PubMed]
51. Critchlow, V.; Barsela, M.; Mountcastle, W.; Liebelt, R.A.; Lipscomb, H.S. Sex difference in resting
pituitary-adrenal function in rat. Am. J. Physiol. 1963, 205, 807–815. [CrossRef] [PubMed]
52. Chisari, A.; Carino, M.; Perone, M.; Gaillard, R.C.; Spinedi, E. Sex and strain variability in the rat
hypothalamo-pituitary-adrenal (HPA) axis function. J. Endocrinol. Investig. 1995, 18, 25–33. [CrossRef]
[PubMed]
53. Griffin, A.C.; Whitacre, C.C. Sex and strain differences in the circadian rhythm fluctuation of endocrine and
immune function in the rat: Implications for rodent models of autoimmune disease. J. Neuroimmunol. 1991,
35, 53–64. [CrossRef]
54. Seale, J.V.; Wood, S.A.; Atkinson, H.C.; Bate, E.; Lightman, S.L.; Ingram, C.D.; Jessop, D.S.;
Harbuz, M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced
hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 2004, 16, 516–524.
[CrossRef] [PubMed]
Brain Sci. 2018, 8, 118 14 of 15
55. Seale, J.V.; Wood, S.A.; Atkinson, H.C.; Harbuz, M.S.; Lightman, S.L. Gonadal steroid replacement
reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced
hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 2004, 16, 989–998.
[CrossRef] [PubMed]
56. Gomez, F.; Manalo, S.; Dallman, M.F. Androgen-sensitive changes in regulation of restraint-induced
adrenocorticotropin secretion between early and late puberty in male rats. Endocrinology 2004, 145, 59–70.
[CrossRef] [PubMed]
57. McCormick, C.M.; Mahoney, E. Persistent effects of prenatal, neonatal, or adult treatment with flutamide
on the hypothalamic-pituitary-adrenal stress response of adult male rats. Horm. Behav. 1999, 35, 90–101.
[CrossRef] [PubMed]
58. Lesniewska, B.; Nowak, M.; Malendowicz, L.K. Sex Differences in Adrenocortical Structure and Function.
Horm. Metab. Res. 1990, 22, 378–381. [CrossRef] [PubMed]
59. Weiser, M.J.; Handa, R.J. Estrogen impairs glucocorticoid dependent negative feedback on the
hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009,
159, 883–895. [CrossRef] [PubMed]
60. Weathington, J.M.; Arnold, A.R.; Cooke, B.M. Juvenile social subjugation induces a sex-specific pattern of
anxiety and depression-like behaviors in adult rats. Horm. Behav. 2012, 61, 91–99. [CrossRef] [PubMed]
61. De Kloet, E.R.; Vreugdenhil, E.; Oitzl, M.S.; Joels, M. Brain corticosteroid receptor balance in health and
disease. Endocr. Rev. 1998, 19, 269–301. [CrossRef] [PubMed]
62. Beato, M. Gene regulation by steroid hormones. Cell 1989, 56, 335–344. [CrossRef]
63. Wallace, A.D.; Cidlowski, J.A. Proteasome-mediated glucocorticoid receptor degradation restricts
transcriptional signaling by glucocorticoids. J. Biol. Chem. 2001, 276, 42714–42721. [CrossRef] [PubMed]
64. Cole, T.J.; Blendy, J.A.; Monaghan, A.P.; Krieglstein, K.; Schmid, W.; Aguzzi, A.; Fantuzzi, G.; Hummler, E.;
Unsicker, K.; Schutz, G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin
cell development and severely retards lung maturation. Genes Dev. 1995, 9, 1608–1621. [CrossRef] [PubMed]
65. Zhang, Y.; Chen, K.N.; Sloan, S.A.; Bennett, M.L.; Scholze, A.R.; O’Keeffe, S.; Phatnani, H.P.; Guarnieri, P.;
Caneda, C.; Ruderisch, N.; et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons,
and Vascular Cells of the Cerebral Cortex. J. Neurosci. 2014, 34, 11929–11947. [CrossRef] [PubMed]
66. Sivukhina, E.; Schafer, H.H.; Jirikowski, G.F. Differences in colocalization of corticosteroid-binding globulin
and glucocorticoid receptor immunoreactivity in the rat brain. Ann. Anat. 2013, 195, 219–224. [CrossRef]
[PubMed]
67. Korn, M.J.; Mandle, Q.J.; Parent, J.M. Conditional Disabled-1 Deletion in Mice Alters Hippocampal
Neurogenesis and Reduces Seizure Threshold. Front. Neurosci. 2016, 10. [CrossRef] [PubMed]
68. Warde-Farley, D.; Donaldson, S.L.; Comes, O.; Zuberi, K.; Badrawi, R.; Chao, P.; Franz, M.; Grouios, C.;
Kazi, F.; Lopes, C.T.; et al. The GeneMANIA prediction server: Biological network integration for gene
prioritization and predicting gene function. Nucleic Acids Res. 2010, 38, W214–W220. [CrossRef] [PubMed]
69. Zuloaga, D.G.; Carbone, D.L.; Handa, R.J. Prenatal dexamethasone selectively decreases calretinin expression
in the adult female lateral amygdala. Neurosci. Lett. 2012, 521, 109–114. [CrossRef] [PubMed]
70. Alcantara, S.; Ruiz, M.; D’Arcangelo, G.; Ezan, F.; de Lecea, L.; Curran, T.; Sotelo, C.; Soriano, E. Regional and
cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci.
1998, 18, 7779–7799. [CrossRef] [PubMed]
71. Wedenoja, J.; Loukola, A.; Tuulio-Henriksson, A.; Paunio, T.; Ekelund, J.; Silander, K.; Varilo, T.; Heikkila, K.;
Suvisaari, J.; Partonen, T.; et al. Replication of linkage on chromosome 7q22 and association of the regional
Reelin gene with working memory in schizophrenia families. Mol. Psychiatry 2008, 13, 673–684. [CrossRef]
[PubMed]
72. Shifman, S.; Johannesson, M.; Bronstein, M.; Chen, S.X.; Collier, D.A.; Craddock, N.J.; Kendler, K.S.; Li, T.;
O’Donovan, M.; O’Neill, F.A.; et al. Genome-wide association identifies a common variant in the reelin gene
that increases the risk of schizophrenia only in women. PLoS Genet. 2008, 4. [CrossRef] [PubMed]
73. Sato, S.; Osanai, H.; Monma, T.; Harada, T.; Hirano, A.; Saito, M.; Kawato, S. Acute effect of corticosterone on
N-methyl-D-aspartate receptor-mediated Ca2+ elevation in mouse hippocampal slices. Biochem. Biophys.
Res. Comm. 2005, 321, 510–513. [CrossRef] [PubMed]
Brain Sci. 2018, 8, 118 15 of 15
74. Zhang, Y.M.; Sheng, H.; Qi, J.S.; Ma, B.; Sun, J.H.; Li, S.F.; Ni, X. Glucocorticoid acts on a putative G
protein-coupled receptor to rapidly regulate the activity of NMDA receptors in hippocampal neurons. Am. J.
Physiol. Endocrinol. Metab. 2012, 302, E747–E758. [CrossRef] [PubMed]
75. Van den Buuse, M.; Halley, P.; Hill, R.; Labots, M.; Martin, S. Altered N-methyl-D-aspartate receptor
function in reelin heterozygous mice: Male-female differences and comparison with dopaminergic activity.
Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 37, 237–246. [CrossRef] [PubMed]
76. Gorski, J.A.; Zeiler, S.R.; Tamowski, S.; Jones, K.R. Brain-derived neurotrophic factor is required for the
maintenance of cortical dendrites. J. Neurosci. 2003, 23, 6856–6865. [CrossRef] [PubMed]
77. Huang, Z.J.; Kirkwood, A.; Pizzorusso, T.; Porciatti, V.; Morales, B.; Bear, M.F.; Maffei, L.; Tonegawa, S. BDNF
regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999,
98, 739–755. [CrossRef]
78. Costa, E.; Davis, J.; Grayson, D.R.; Guidotti, A.; Pappas, G.D.; Pesold, C. Dendritic spine hypoplasticity
and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 2001, 8,
723–742. [CrossRef] [PubMed]
79. Lussier, A.L.; Romay-Tallon, R.; Caruncho, H.J.; Kalynchuk, L.E. Altered GABAergic and glutamatergic
activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration
but not restraint stress. Neuroscience 2013, 231, 38–48. [CrossRef] [PubMed]
80. Filipovic, D.; Zlatkovic, J.; Gass, P.; Inta, D. The differential effects of acute vs. chronic stress and their
combination on hippocampal parvalbumin and inducible heat shock protein 70 expression. Neuroscience
2013, 236, 47–54. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
